Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Remifentanil and Dexmedetomidine in Patients With Noninvasive Mechanical Ventilation Intolerance After Cardiac Surgery
NCT04734418Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Mar 2021
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of remifentanil (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Remission rate of intolerance in patients with intolerance of non-invasive mechanical ventilation after cardiac surgery at 72 hours. Status: unknown.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT04734418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04734418.